In-vitro Diagnostics Enzymes Market Size, Share & Trends Report

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68039-246-6
  • Number of Pages: 199
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Information or Data Analysis
                 1.3 Market Model
                      1.3.1 Parent market Study
                           1.3.1.1 Global enzymes market
                           1.3.1.2 Global IVD market
                           1.3.1.3 Market study, by region
                 1.4 Objectives
                      1.4.1 Objective 1:
                      1.4.2 Objective 2:
Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Segment Outlook
                 2.3 Competitive Insights
                 2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Trends and Outlook
                 3.2 Market Segmentation and Scope
                 3.3 Market Lineage Outlook
                      3.3.1 Parent Market Analysis
                           3.3.1.1 IVD market 
                           3.3.1.2 MOLECULAR Biology Enzymes And Kits market 
                 3.4 Pricing Analysis
                      3.4.1 Pricing for Proteases: Bulk Orders
                      3.4.2 Pricing for Proteases: General Orders
                      3.4.3 Pricing for IVD Grade Proteases: General Orders
                 3.5 Impact of COVID-19
                 3.6 Business Environment Analysis
                      3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
                      3.6.2 Porter’s Five Forces Analysis
                 3.7 Penetration and Growth Prospect Mapping for technology type, 2019 (USD Million)
Chapter 4 Market Dynamics
                 4.1 Market driver analysis
                      4.1.1 Rise in demand for enzyme biosensors for point of care testing
                      4.1.2 Wide applications of enzymes in pathology
                      4.1.3 Advancements in diagnostic testing of viral infections
                 4.2 Market Restraint Analysis
                      4.2.1 Regulatory & reimbursement hurdles for in-vitro diagnostics
                      4.2.2 High cost of enzyme-based diagnostic test
                 4.3 Market Opportunity Analysis
                      4.3.1 Advances in Molecular Diagnostics Technologies
                 4.4 Market Challenge Analysis
                      4.4.1 Challenges associated with clinical chemistry testing
Chapter 5 IVD Enzymes Market: Enzyme Type Estimates & Trend Analysis
                 5.1 Segment Definition
                 5.2 Market Formulation and Modelling
                 5.3 IVD Enzymes Market: Enzyme Type Movement Analysis
                 5.4 Proteases
                      5.4.1 IVD proteases market, 2016 - 2027 (USD Million)
                      5.4.2 By Therapeutic Area
                           5.4.2.1 Segment Definition
                           5.4.2.2 Infectious diseases
                                5.4.2.2.1 IVD proteases market for infectious diseases, 2016 - 2027 (USD Million)
                           5.4.2.3 Diabetes
                                5.4.2.3.1 IVD proteases market for diabetes, 2016 - 2027 (USD Million)
                           5.4.2.4 Oncology
                                5.4.2.4.1 IVD proteases market for oncology, 2016 - 2027 (USD Million)
                           5.4.2.5 Cardiology
                                5.4.2.5.1 IVD proteases market for cardiology, 2016 - 2027 (USD Million)
                           5.4.2.6 Nephrology
                                5.4.2.6.1 IVD proteases market for nephrology, 2016 - 2027 (USD Million)
                           5.4.2.7 Autoimmune Diseases
                                5.4.2.7.1 IVD proteases market for autoimmune diseases, 2016 - 2027 (USD Million)
                           5.4.2.8 Others
                                5.4.2.8.1 IVD proteases market for other diseases, 2016 - 2027 (USD Million)
                      5.4.3 By Technology type Use
                           5.4.3.1 Segment Definition
                           5.4.3.2 Histology Assays
                                5.4.3.2.1 IVD proteases market for histology assays, 2016 - 2027 (USD Million)
                           5.4.3.3 Molecular Diagnostics
                                5.4.3.3.1 IVD proteases market for molecular diagnostics, 2016 - 2027 (USD Million)
                                5.4.3.3.2 PCR Assays
                                     5.4.3.3.2.1 IVD proteases market for PCR assays, 2016 - 2027 (USD Million)
                                5.4.3.3.3 NGS Assays
                                     5.4.3.3.3.1 IVD proteases market for NGS assays, 2016 - 2027 (USD Million)
                                5.4.3.3.4 Others
                                     5.4.3.3.4.1 IVD proteases market for other assays, 2016 - 2027 (USD Million)
                           5.4.3.4 Clinical chemistry
                                     5.4.3.4.1 IVD proteases market for clinical chemistry, 2016 - 2027 (USD Million)
                      5.4.4 By Physical Form
                           5.4.4.1 Segment Definition
                           5.4.4.2 Powder
                                5.4.4.2.1 Powder IVD proteases market, 2016 - 2027 (USD Million)
                           5.4.4.3 Liquid
                                5.4.4.3.1 Liquid IVD proteases market, 2016 - 2027 (USD Million)
                      5.4.5 By Type
                           5.4.5.1 Segment Definition
                           5.4.5.2 Natural
                                5.4.5.2.1 Natural IVD proteases market, 2016 - 2027 (USD Million)
                           5.4.5.3 Recombinant
                                5.4.5.3.1 Recombinant IVD proteases market, 2016 - 2027 (USD Million)
                      5.4.6 By End Use
                           5.4.6.1 Segment Definition
                           5.4.6.2 Pharma & Biotech
                                5.4.6.2.1 IVD proteases market for pharma & biotech companies, 2016 - 2027 (USD Million)
                           5.4.6.3 Hospital & Diagnostic Labs
                                5.4.6.3.1 IVD proteases market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
                           5.4.6.4 CROs
                                5.4.6.4.1 IVD proteases market for CROs, 2016 - 2027 (USD Million)
                           5.4.6.5 Academic labs
                                5.4.6.5.1 IVD proteases market for academic labs, 2016 - 2027 (USD Million)
                 5.5 Polymerase & Transcriptase
                      5.5.1 IVD polymerase & transcriptase market, 2016 - 2027 (USD Million)
                 5.6 Ribonuclease
                      5.6.1 IVD ribonuclease market, 2016 - 2027 (USD Million)
                 5.7 Others
                      5.7.1 Other IVD enzymes market, 2016 - 2027 (USD Million)
Chapter 6 IVD Enzymes Market: Therapeutic Area Estimates & Trend Analysis
                 6.1 Segment Definition
                 6.2 Market Formulation and Modelling
                 6.3 IVD Enzymes Market: Therapeutic Area Movement Analysis
                 6.4 Infectious Disease
                      6.4.1 IVD enzymes market for infectious disease, 2016 - 2027 (USD Million)
                      6.4.2 COVID-19 Testing
                           6.4.2.1 IVD enzymes market for COVID-19 testing, 2016 - 2027 (USD Million)
                      6.4.3 Hepatitis
                           6.4.3.1 IVD enzymes market for hepatitis, 2016 - 2027 (USD Million)
                      6.4.4 HIV
                           6.4.4.1 IVD enzymes market for HIV, 2016 - 2027 (USD Million)
                      6.4.5 Other infectious diseases
                           6.4.5.1 IVD enzymes market for other infectious diseases, 2016 - 2027 (USD Million)
                 6.5 Diabetes
                      6.5.1 IVD enzymes market for diabetes, 2016 - 2027 (USD Million)
                 6.6 Oncology
                      6.6.1 IVD enzymes market for oncology, 2016 - 2027 (USD Million)
                 6.7 Cardiology
                      6.7.1 IVD enzymes market for cardiology, 2016 - 2027 (USD Million)
                 6.8 Nephrology
                      6.8.1 IVD enzymes market for nephrology, 2016 - 2027 (USD Million)
                 6.9 Autoimmune Diseases
                      6.9.1 IVD enzymes market for autoimmune diseases, 2016 - 2027 (USD Million)
                 6.10 Others
                      6.10.1 IVD enzymes market for other diseases, 2016 - 2027 (USD Million)
Chapter 7 IVD Enzymes Market: Technology Type Estimates & Trend Analysis
                 7.1 Segment Definition
                 7.2 Market Formulation and Modelling
                 7.3 IVD Enzymes Market: Technology Type Movement Analysis
                 7.4 Histology Assays
                      7.4.1 IVD enzymes market for histology assays, 2016 - 2027 (USD Million)
                 7.5 Molecular Diagnostics
                      7.5.1 IVD enzymes market for molecular diagnostics, 2016 - 2027 (USD Million)
                      7.5.2 PCR Assays
                           7.5.2.1 IVD enzymes market for PCR assays, 2016 - 2027 (USD Million)
                      7.5.3 NGS Assays
                           7.5.3.1 IVD enzymes market for NGS assays, 2016 - 2027 (USD Million)
                      7.5.4 Others
                           7.5.4.1 IVD enzymes market for other molecular biology assays, 2016 - 2027 (USD Million)
                 7.6 Clinical Chemistry
                      7.6.1 IVD enzymes market for clinical chemistry, 2016 - 2027 (USD Million)
Chapter 8 IVD Enzymes Market: End-use Estimates & Trend Analysis
                 8.1 Segment Definition
                 8.2 Market Formulation and Modelling
                 8.3 IVD Enzymes Market: End-use Movement Analysis
                 8.4 Pharma & Biotech
                      8.4.1 IVD enzymes market for pharma & biotech, 2016 - 2027 (USD Million)
                 8.5 Hospital & Diagnostic Labs
                      8.5.1 IVD enzymes market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
                 8.6 CROs
                      8.6.1 IVD enzymes market for CROs, 2016 - 2027 (USD Million)
                 8.7 Academic Labs
                      8.7.1 IVD enzymes market for academic labs, 2016 - 2027 (USD Million)
Chapter 9 IVD Enzymes Market: Regional Estimates & Trend Analysis
                 9.1 Market: Regional Movement Analysis
                 9.2 North America
                      9.2.1 Market estimates and forecast, 2016-2027 (USD Million)
                      9.2.2 U.S.
                           9.2.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.2.2.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.2.2.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.2.2.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.2.2.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.2.3 Canada
                           9.2.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.2.3.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.2.3.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.2.3.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.2.3.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                 9.3 Europe
                      9.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                      9.3.2 Germany
                           9.3.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.3.2.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.3.2.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.3.2.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.3.2.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.3.3 France
                           9.3.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.3.3.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.3.3.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.3.3.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.3.3.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.3.4 U.K.
                           9.3.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.3.4.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.3.4.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.3.4.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.3.4.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.3.5 Italy
                           9.3.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.3.5.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.3.5.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.3.5.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.3.5.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.3.6 Spain
                           9.3.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.3.6.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.3.6.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.3.6.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.3.6.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                 9.4 Asia Pacific
                      9.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                      9.4.2 Japan
                           9.4.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.4.2.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.4.2.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.4.2.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.4.2.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.4.3 China
                           9.4.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.4.3.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.4.3.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.4.3.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.4.3.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.4.4 India
                           9.4.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.4.4.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.4.4.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.4.4.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.4.4.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                 9.5 Latin America
                      9.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                      9.5.2 Brazil
                           9.5.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.5.2.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.5.2.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.5.2.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.5.2.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                      9.5.3 Mexico
                           9.5.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.5.3.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.5.3.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.5.3.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.5.3.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
                 9.6 Middle East & Africa (MEA)
                      9.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                      9.6.2 South Africa
                           9.6.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
                           9.6.2.2 Market estimates and forecast, by enzyme type 2016 - 2027 (USD Million)
                           9.6.2.3 Market estimates and forecast, by therapeutic area 2016 - 2027 (USD Million)
                           9.6.2.4 Market estimates and forecast, by technology type 2016 - 2027 (USD Million)
                           9.6.2.5 Market estimates and forecast, by end-use 2016 - 2027 (USD Million)
Chapter 10 Competitive Landscape
                 10.1 Strategy Framework
                 10.2 Market Participation Categorization
                 10.3 Company Profiles
                      10.3.1 Merck KGaA
                           10.3.1.1 Company overview
                           10.3.1.2 Sigma-Aldrich Co. LLC
                                10.3.1.2.1 Company overview
                           10.3.1.3 Financial performance
                           10.3.1.4 Product benchmarking
                           10.3.1.5 Strategic initiatives
                      10.3.2 Codexis
                           10.3.2.1 Company overview
                           10.3.2.2 Financial performance
                           10.3.2.3 Product benchmarking
                           10.3.2.4 Strategic initiatives
                      10.3.3 F. Hoffmann-La Roche Ltd.
                           10.3.3.1 Company overview
                           10.3.3.2 Financial performance
                           10.3.3.3 Product benchmarking
                           10.3.3.4 Strategic initiatives
                      10.3.4 Amano Enzymes
                           10.3.4.1 Company overview
                           10.3.4.2 Financial performance
                           10.3.4.3 Product benchmarking
                           10.3.4.4 Strategic initiatives
                      10.3.5 Advanced Enzymes Technologies Ltd.
                           10.3.5.1 Company overview
                           10.3.5.2 Financial performance
                           10.3.5.3 Product benchmarking
                           10.3.5.4 Strategic initiatives
                      10.3.6 Biocatalysts Ltd.
                           10.3.6.1 Company overview
                           10.3.6.2 Financial performance
                           10.3.6.3 Product benchmarking
                           10.3.6.4 Strategic initiatives
                      10.3.7 Amicogen
                           10.3.7.1 Company overview
                           10.3.7.2 Financial performance
                           10.3.7.3 Product benchmarking
                           10.3.7.4 Strategic initiatives
                      10.3.8 Dyadic International
                           10.3.8.1 Company overview
                           10.3.8.2 Financial performance
                           10.3.8.3 Product benchmarking
                           10.3.8.4 Strategic initiatives
                       10.3.9 BBI Solutions
                           10.3.9.1 Company overview
                           10.3.9.2 Financial performance
                           10.3.9.3 Product benchmarking
                           10.3.9.4 Strategic initiatives
                      10.3.10 Affymetrix
                           10.3.10.1 Company overview
                           10.3.10.2 Financial performance
                           10.3.10.3 Product benchmarking
                           10.3.10.4 Strategic initiatives
                      10.3.11 American Laboratories
                           10.3.11.1 Company overview
                           10.3.11.2 Financial performance
                           10.3.11.3 Product benchmarking
                           10.3.11.4 Strategic initiatives


List of Tables

Table 1 Pricing for Acid Proteases: Bulk Orders
Table 2 Pricing for Alkaline Proteases: Bulk Orders
Table 3 Pricing for Neutral Proteases: Bulk Orders
Table 4 Pricing for Proteases from Aspergillus oryzae: General Orders
Table 5 Pricing for Proteases from Bacillus amyloliquefaciens: General Orders
Table 6 Pricing for Proteases from Bacillus licheniformis: General Orders
Table 7 Pricing for Proteases from Bacillus sp: General Orders
Table 8 Pricing for Proteases from Streptomyces griseus: General Orders
Table 9 Pricing for Proteases from Streptomyces griseus: General Orders
Table 10 Pricing for Proteases from Aspergillus melleus: General Orders
Table 11 Pricing for IVD grade trypsin from bovine pancreas
Table 12 Pricing for IVD grade trypsin from porcine pancreas
Table 13 Pricing for IVD grade pepsin from porcine gastric mucosa
Table 14 List of molecular tests for COVID-19 diagnosis
Table 15 List of antigen diagnostic tests for COVID-19 diagnosis
Table 16 List of home-based molecular tests for COVID-19 diagnosis
Table 17 Commercial Enzymatic Biosensors for Clinical Applications
Table 18 Commercial availability of proteases commonly used for fragmenting proteins
Table 19 Enzymes in diagnosis of diseases
Table 20 Percentage breakdown of revenue (2019) for infectious disease, by enzyme type
Table 21 Percentage breakdown of revenue (2019) for diabetes, by enzyme type
Table 22 Percentage breakdown of revenue (2019) for oncology, by enzyme type
Table 23 Percentage breakdown of revenue (2019) for cardiology, by enzyme type
Table 24 Percentage breakdown of revenue (2019) for nephrology, by enzyme type
Table 25 Percentage breakdown of revenue (2019) for autoimmune diseases, by enzyme type
Table 26 Percentage breakdown of revenue (2019) for other diseases, by enzyme type
Table 27 Clinical chemistry: Key enzymes
Table 28 North America IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 29 North America protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 30 North America protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 31 North America molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 32 North America protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 33 North America protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 34 North America protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 35 North America IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 36 North America infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 37 North America IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 38 North America molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 39 North America IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 40 U.S. IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 41 U.S. protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 42 U.S. protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 43 U.S. molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 44 U.S. protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 45 U.S. protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 46 U.S. protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 47 U.S. IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 48 U.S. infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 49 U.S. IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 50 U.S. molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 51 U.S. IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 52 Canada IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 53 Canada protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 54 Canada protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 55 Canada molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 56 Canada protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 57 Canada protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 58 Canada protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 59 Canada IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 60 Canada infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 61 Canada IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 62 Canada molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 63 Canada IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 64 Europe IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 65 Europe protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 66 Europe protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 67 Europe molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 68 Europe protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 69 Europe protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 70 Europe protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 71 Europe IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 72 Europe infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 73 Europe IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 74 Europe molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 75 Europe IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 76 Germany IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 77 Germany protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 78 Germany protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 79 Germany molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 80 Germany protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 81 Germany protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 82 Germany protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 83 Germany IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 84 Germany infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 85 Germany IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 86 Germany molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 87 Germany IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 88 France IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 89 France protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 90 France protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 91 France molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 92 France protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 93 France protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 94 France protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 95 France IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 96 France infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 97 France IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 98 France molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 99 France IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 100 U.K. IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 101 U.K. protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 102 U.K. protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 103 U.K. molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 104 U.K. protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 105 U.K. protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 106 U.K. protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 107 U.K. IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 108 U.K. infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 109 U.K. IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 110 U.K. molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 111 U.K. IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 112 Italy IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 113 Italy protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 114 Italy protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 115 Italy molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 116 Italy protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 117 Italy protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 118 Italy protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 119 Italy IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 120 Italy infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 121 Italy IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 122 Italy molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 123 Italy IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 124 Spain IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 125 Spain protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 126 Spain protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 127 Spain molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 128 Spain protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 129 Spain protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 130 Spain protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 131 Spain IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 132 Spain infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 133 Spain IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 134 Spain molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 135 Spain IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 136 Enzyme suppliers in Asia
Table 137 Asia Pacific IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 138 Asia Pacific protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 139 Asia Pacific protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 140 Asia Pacific molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 141 Asia Pacific protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 142 Asia Pacific protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 143 Asia Pacific protease market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
Table 144 Asia Pacific IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 145 Asia Pacific infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 146 Asia Pacific IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 147 Asia Pacific molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 148 Asia Pacific IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 149 Japan IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 150 Japan protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 151 Japan protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 152 Japan molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 153 Japan protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 154 Japan protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 155 Japan protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 156 Japan IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 157 Japan infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 158 Japan IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 159 Japan molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 160 Japan IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 161 China IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 162 China protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 163 China protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 164 China molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 165 China protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 166 China protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 167 China protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 168 China IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 169 China infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 170 China IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 171 China molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 172 China IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 173 India IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 174 India protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 175 India protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 176 India molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 177 India protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 178 India protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 179 India protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 180 India IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 181 India infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 182 India IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 183 India molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 184 India IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 185 Latin America IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 186 Latin America protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 187 Latin America protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 188 Latin America molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 189 Latin America protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 190 Latin America protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 191 Latin America protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 192 Latin America IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 193 Latin America infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 194 Latin America IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 195 Latin America molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 196 Latin America IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 197 Brazil IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 198 Brazil protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 199 Brazil protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 200 Brazil molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 201 Brazil protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 202 Brazil protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 203 Brazil protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 204 Brazil IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 205 Brazil infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 206 Brazil IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 207 Brazil molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 208 Brazil IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 209 Mexico IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 210 Mexico protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 211 Mexico protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 212 Mexico molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 213 Mexico protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 214 Mexico protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 215 Mexico protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 216 Mexico IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 217 Mexico infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 218 Mexico IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 219 Mexico molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 220 Mexico IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 221 MEA IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 222 MEA protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 223 MEA protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 224 MEA molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 225 MEA protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 226 MEA protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 227 MEA protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 228 MEA IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 229 MEA infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 230 MEA IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 231 MEA molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 232 MEA IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 233 South Africa IVD enzymes market estimates & forecasts, by enzyme type, 2016 - 2027 (USD Million)
Table 234 South Africa protease market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 235 South Africa protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 236 South Africa molecular diagnostics protease market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 237 South Africa protease market estimates & forecasts, by physical form, 2016 - 2027 (USD Million)
Table 238 South Africa protease market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 239 South Africa protease market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)
Table 240 South Africa IVD enzymes market estimates & forecasts, by therapeutic area, 2016 - 2027 (USD Million)
Table 241 South Africa infectious disease IVD enzymes market estimates & forecasts, by type, 2016 - 2027 (USD Million)
Table 242 South Africa IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 243 South Africa molecular diagnostics IVD enzymes market estimates & forecasts, by technology type, 2016 - 2027 (USD Million)
Table 244 South Africa IVD enzymes market estimates & forecasts, by end-use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation and validation
Fig. 8 Market model for IVD enzymes market derived from enzymes market
Fig. 9 Penetration of diagnostic enzymes in the global specialty enzymes market
Fig. 10 Market model for IVD enzymes market derived from the IVD market
Fig. 11 Enzyme demand, by region
Fig. 12 Enzyme suppliers, by country
Fig. 13 Market snapshot (USD Million for 2019)
Fig. 14 Market trends & outlook
Fig. 15 Market segmentation
Fig. 16 Total number of COVID-19 cases, by country
Fig. 17 Total number of deaths due to COVID-19, by country
Fig. 18 Number of COVID-19 tests performed, by country
Fig. 19 Types of COVID-19 tests
Fig. 20 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 21 Porter’s Five Forces Analysis
Fig. 22 Penetration and growth prospect mapping, 2019 (USD Million)
Fig. 23 IVD enzymes market drivers impact
Fig. 24 Enzyme-based biosensors in clinical diagnosis
Fig. 25 IVD enzymes market restraints impact
Fig. 26 IVD enzymes market opportunity impact
Fig. 27 IVD enzymes market challenge impact
Fig. 28 Segment Definition
Fig. 29 Commodity flow analysis modeling for enzyme types
Fig. 30 IVD enzymes market: Enzyme type outlook and key takeaways
Fig. 31 Common diagnostic enzymes
Fig. 32 IVD enzymes market: Enzyme type movement analysis
Fig. 33 Global IVD proteases market, 2016 - 2027 (USD Million)
Fig. 34 Segment Definition
Fig. 35 Global IVD proteases market for infectious diseases, 2016 - 2027 (USD Million)
Fig. 36 Global IVD proteases market for diabetes, 2016 - 2027 (USD Million)
Fig. 37 Global IVD proteases market for oncology, 2016 - 2027 (USD Million)
Fig. 38 Global IVD proteases market for cardiology, 2016 - 2027 (USD Million)
Fig. 39 Global IVD proteases market for nephrology, 2016 - 2027 (USD Million)
Fig. 40 Global IVD proteases market for autoimmune diseases, 2016 - 2027 (USD Million)
Fig. 41 Global IVD proteases market for other diseases, 2016 - 2027 (USD Million)
Fig. 42 Segment Definition
Fig. 43 Global IVD proteases market for histology assays, 2016 - 2027 (USD Million)
Fig. 44 Global IVD proteases market for molecular diagnostics, 2016 - 2027 (USD Million)
Fig. 45 Global IVD proteases market for PCR assays, 2016 - 2027 (USD Million)
Fig. 46 Global IVD proteases market for NGS assays, 2016 - 2027 (USD Million)
Fig. 47 Global IVD proteases market for other assays, 2016 - 2027 (USD Million)
Fig. 48 Global IVD proteases market for clinical chemistry, 2016 - 2027 (USD Million)
Fig. 49 Segment Definition
Fig. 50 Powder IVD proteases market, 2016 - 2027 (USD Million)
Fig. 51 Liquid IVD proteases market, 2016 - 2027 (USD Million)
Fig. 52 Segment Definition
Fig. 53 Natural IVD proteases market, 2016 - 2027 (USD Million)
Fig. 54 Recombinant IVD proteases market, 2016 - 2027 (USD Million)
Fig. 55 Segment Definition
Fig. 56 Global IVD proteases market for pharma & biotech companies, 2016 - 2027 (USD Million)
Fig. 57 Global IVD proteases market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
Fig. 58 Global IVD proteases market for CROs, 2016 - 2027 (USD Million)
Fig. 59 Global IVD proteases market for academic labs, 2016 - 2027 (USD Million)
Fig. 60 Diamond Taq family polymerases: Specifications
Fig. 61 Global IVD polymerase & transcriptase market, 2016 - 2027 (USD Million)
Fig. 62 Global IVD ribonuclease market, 2016 - 2027 (USD Million)
Fig. 63 Global other IVD enzymes market, 2016 - 2027 (USD Million)
Fig. 64 Segment Definition
Fig. 65 Penetration of therapeutic area in IVD enzymes market
Fig. 66 IVD enzymes market: Therapeutic area outlook and key takeaways
Fig. 67 IVD enzymes market: Therapeutic area movement analysis
Fig. 68 Global IVD enzymes market for infectious disease, 2016 - 2027 (USD Million)
Fig. 69 Global IVD enzymes market for COVID-19 testing, 2016 - 2027 (USD Million)
Fig. 70 Global IVD enzymes market for hepatitis, 2016 - 2027 (USD Million)
Fig. 71 Global IVD enzymes market for HIV, 2016 - 2027 (USD Million)
Fig. 72 Global IVD enzymes market for other infectious diseases, 2016 - 2027 (USD Million)
Fig. 73 Global IVD enzymes market for diabetes, 2016 - 2027 (USD Million)
Fig. 74 Global IVD enzymes market for oncology, 2016 - 2027 (USD Million)
Fig. 75 Global IVD enzymes market for cardiology, 2016 - 2027 (USD Million)
Fig. 76 Global IVD enzymes market for nephrology, 2016 - 2027 (USD Million)
Fig. 77 Global IVD enzymes market for autoimmune diseases, 2016 - 2027 (USD Million)
Fig. 78 Global IVD enzymes market for other diseases, 2016 - 2027 (USD Million)
Fig. 79 Segment Definition
Fig. 80 Penetration of technology type in molecular diagnostics techniques sub-type
Fig. 81 IVD enzymes market: Technology type outlook and key takeaways
Fig. 82 IVD enzymes market: Technology type movement analysis
Fig. 83 Utility of enzymes in pretreatment during ISH and fluorescence in situ hybridization
Fig. 84 Global IVD enzymes market for histology assays, 2016 - 2027 (USD Million)
Fig. 85 Global IVD enzymes market for molecular diagnostics, 2016 - 2027 (USD Million)
Fig. 86 Global IVD enzymes market for PCR assays, 2016 - 2027 (USD Million)
Fig. 87 Enzymes used in NGS library preparation
Fig. 88 Global IVD enzymes market for NGS assays, 2016 - 2027 (USD Million)
Fig. 89 Global IVD enzymes market for other molecular biology assays, 2016 - 2027 (USD Million)
Fig. 90 Global IVD enzymes market for clinical chemistry, 2016 - 2027 (USD Million)
Fig. 91 Segment Definition
Fig. 92 Penetration by end-use settings
Fig. 93 IVD enzymes market: End-use outlook and key takeaways
Fig. 94 IVD enzymes market: End-use movement analysis
Fig. 95 Global IVD enzymes market for pharma & biotech, 2016 - 2027 (USD Million)
Fig. 96 Global IVD enzymes market for hospital & diagnostic labs, 2016 - 2027 (USD Million)
Fig. 97 Global IVD enzymes market for CROs, 2016 - 2027 (USD Million)
Fig. 98 Global IVD enzymes market for academic labs, 2016 - 2027 (USD Million)
Fig. 99 IVD enzymes market: Regional outlook and key takeaways
Fig. 100 IVD enzymes market: Regional movement analysis
Fig. 101 North America
Fig. 102 North America IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 103 U.S.
Fig. 104 U.S. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 105 Canada
Fig. 106 Canada IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 107 Europe
Fig. 108 Europe IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 109 Germany
Fig. 110 Germany IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 111 France
Fig. 112 France IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 113 U.K.
Fig. 114 U.K. IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 115 Italy
Fig. 116 Italy IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 117 Spain
Fig. 118 Spain IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 119 Asia Pacific
Fig. 120 Asia Pacific IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 121 Japan
Fig. 122 Japan IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 123 China
Fig. 124 China IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 125 India
Fig. 126 India IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 127 Latin America
Fig. 128 Latin America IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 129 Brazil
Fig. 130 Brazil IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 131 Mexico
Fig. 132 Mexico IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 133 MEA
Fig. 134 MEA IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 135 South Africa
Fig. 136 South Africa IVD enzymes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 137 Strategy framework
Fig. 138 Market participation categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon